Related Experiment Video
Updated: Apr 19, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
ERK (MAPK) does not phosphorylate tau under physiological conditions in vivo or in vitro
Anastasia Noël1, Isabelle Poitras1, Jacinthe Julien2
1Département de Psychiatrie et Neurosciences, Faculté de médecine, Université Laval, Québec, Quebec, Canada; Centre Hospitalier de l'Université Laval, Axe Neurosciences, Québec, Quebec, Canada.
Abstract:
Alzheimer's disease is characterized by the deposition of intracellular aggregates of hyperphosphorylated tau protein. Tau hyperphosphorylation has been attributed in part to the deregulation of kinases and phosphatases activities. Extracellular signal regulated-kinases 1/2 (ERK1/2) were reported to be activated in the first stages of Alzheimer's disease and were proposed as a potential therapeutic target. However, although the phosphorylation of tau by ERK1/2 has been demonstrated in cell-free system, it remains controversial in vivo. Here, we showed that pharmacologic inhibition of ERK1/2 in mice and SH-SY5Y cells did not reduce basal levels of phospho-tau or hypothermia-induced tau hyperphosphorylation. We also found that activating ERK1/2 by hyperthermia did not correlate with increased tau phosphorylation. Finally, ERK1/2 was inhibited, but tau phosphorylation was not altered in Mek1-/- mice. In conclusion, these results do not support the involvement of ERK1/2 in tau phosphorylation under physiological conditions.
Insights
Extracellular signal-regulated kinases 1/2 (ERK1/2) do not appear to play a significant role in tau protein phosphorylation in Alzheimer's disease models. Studies show inhibiting or activating ERK1/2 did not alter tau phosphorylation levels.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Alzheimer's disease involves intracellular tau protein aggregates due to hyperphosphorylation.
- Dysregulated kinase and phosphatase activity contributes to tau hyperphosphorylation.
- Extracellular signal-regulated kinases 1/2 (ERK1/2) are implicated in early Alzheimer's disease stages and considered a therapeutic target.
Purpose of the Study:
- To investigate the in vivo role of ERK1/2 in tau phosphorylation.
- To determine if ERK1/2 inhibition or activation affects tau phosphorylation under physiological and induced conditions.
Main Methods:
- Pharmacologic inhibition of ERK1/2 in mice and SH-SY5Y cells.
- Induction of tau hyperphosphorylation via hypothermia and ERK1/2 activation via hyperthermia.
- Analysis of tau phosphorylation in Mek1-/- mice with inhibited ERK1/2.
Main Results:
- Pharmacologic ERK1/2 inhibition did not alter basal or hypothermia-induced phospho-tau levels.
- Hyperthermia-induced ERK1/2 activation did not correlate with increased tau phosphorylation.
- Inhibition of ERK1/2 in Mek1-/- mice did not affect tau phosphorylation.
Conclusions:
- The findings do not support the involvement of ERK1/2 in tau phosphorylation under physiological conditions.
- ERK1/2 may not be a suitable therapeutic target for reducing tau hyperphosphorylation in Alzheimer's disease.
Related Concept Videos
Microtubule Associated Proteins (MAPs)
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
MAPK Signaling Cascades
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Microtubule Instability

